Periodic reports
Please be informed that, as Celon Pharma S.A. is listed on the Warsaw Stock Exchange (WSE), we are obliged to publish our financial results in Polish. Below you can find historical financial reports of the Company.
In the “Materials” section, we provide presentations summarizing and commenting on the results for each reporting period in English. Should you wish to obtain any additional financial materials, please contact our Investor Relations Department which will be happy to prepare them for you.
Contact us: [email protected]
2026
First Quarter Report
2025
Annual FIN Report 2025
Annual Management Board & ESG Report
Report Q3 2025
Report H1 2025
First Quarter Report
2024
Annual Report 2024
Report Q3 2024
Report H1 2024
First Quarter Report
2023
Annual Report 2023
Third Quarter Report
Corrected Report 1H 2023
Report 1H 2023
First Quarter Report
2022
H1 Report
2021
1st quarter report
Annual report
Annual report
1H Financial Report
Q3 Report
2020
IFRS financial statements 2018-2020
Annual report
3rd quarter report
Semi-annual report
1st quarter report
2019
Annual Report
Semi-annual report
Third quarter report
1st quarter report
2018
Annual Report
E – Report
Semi-annual report
Third quarter report
1st quarter report
2017
Annual Report
Semi-annual report
Third quarter report
1st quarter report
2016
Annual Report
Third quarter report
Additional information to the Celon Pharma S.A. quarterly report for the third quarter of 2016
Other information for the Celon Pharma S.A. quarterly report for the third quarter of 2016